Exabis Library
Welcome to the e-CCO Library!
P450: A gender comparison of the association between coping strategies and perceived social support in Crohn’s disease patients
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P450: Association of Infliximab trough levels and transmural healing in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P450: Mind the gap: Why do physicians underestimate their patient's adherence?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P450: Real life Effectiveness and safety of an induction treatment with tofacitinib in patients with Ulcerative Colitis: First results of the French TOFAST cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P450: Reliability assessment of endoscopic scoring tools using central video review of colonoscopies in paediatric patients with ulcerative colitis: data from the Canadian Children IBD Network
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P450: Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P450: Vaccination strategies in Inflammatory Bowel Disease patients: perspective of physicians and patients.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P451 Short-and long-term effectiveness of ustekinumab in patients with Crohn’s disease: real-world data from a German IBD cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P451: Compound IBD patient profiles are related to specific information needs – an Israeli national survey
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P451: Early infliximab trough levels in paediatric IBD patients predict sustained remission
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P451: Efficacy and safety of tofacitinib in the treatment of patients with active, moderate to severe, Ulcerative Colitis: a systematic review and meta-analysis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P451: Evaluating drug sustainability, efficacy and safety of biologic agents in elderly patients with Inflammatory Bowel Disease: a single center retrospective study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P451: Long-term surgical outcome of ileal pouch-anal anastomosis when used for well-defined Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P451: Safety and efficacy of ferric carboxymaltose (FCM) for the treatment of iron deficiency anaemia in paediatric patients affected by inflammatory bowel disease (pIBD)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P451: The efficacy of infliximab in tacrolomus non-responder with ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P452 Biologic use patterns and predictors for non-persistence and switching of biologics in patients with inflammatory bowel disease: a nationwide population-based study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P452: Fecal Microbiota Transplantation Leads to Lower IBD Related Complications in Hospitalized Inflammatory Bowel Disease Patients with Clostridioides difficile Infection: A retrospective cohort study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P452: Impact of implementing a rapid access clinic in a high-volume inflammatory bowel disease centre: accessibility, resource utilisation and outcomes
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P452: Medium to long-term outcomes in patients receiving accelerated dose infliximab induction for acute severe ulcerative colitis (ASUC) in a multi-centre cohort
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P452: Oral ciclosporin is a convenient, effective and safe rescue therapy in steroid refractory Acute Severe Ulcerative Colitis: A single tertiary centre experience
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM